D
Daniel Kirschenbaum
Researcher at University of Zurich
Publications - 28
Citations - 867
Daniel Kirschenbaum is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 10, co-authored 22 publications receiving 492 citations. Previous affiliations of Daniel Kirschenbaum include University of Tübingen.
Papers
More filters
Journal ArticleDOI
The mesoSPIM initiative: open-source light-sheet microscopes for imaging cleared tissue
Fabian F. Voigt,Daniel Kirschenbaum,Evgenia Platonova,Stéphane Pagès,Robert A. A. Campbell,Rahel Kastli,Martina Schaettin,Ladan Egolf,Alexander van der Bourg,Philipp Bethge,Karen Haenraets,Noémie Frezel,Thomas Topilko,Paola Perin,Daniel Hillier,Daniel Hillier,Sven Hildebrand,Anna Schueth,Alard Roebroeck,Botond Roska,Esther T. Stoeckli,Roberto Pizzala,Nicolas Renier,Hanns Ulrich Zeilhofer,Theofanis Karayannis,Urs Ziegler,Laura Batti,Anthony Holtmaat,Christian Lüscher,Christian Lüscher,Adriano Aguzzi,Fritjof Helmchen +31 more
TL;DR: The mesoscale selective plane-illumination microscopy initiative is introduced, an open-hardware project for building and operating a light-sheet microscope that addresses these challenges and is compatible with any type of cleared or expanded sample.
Journal ArticleDOI
Impaired Action Potential Initiation in GABAergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation
Ulrike B. S. Hedrich,Camille Liautard,Daniel Kirschenbaum,Martin Pofahl,Jennifer Lavigne,Jennifer Lavigne,Yuanyuan Liu,Stephan Theiss,Johannes Slotta,Andrew Escayg,Marcel Dihné,Heinz Beck,Heinz Beck,Massimo Mantegazza,Massimo Mantegazza,Holger Lerche +15 more
TL;DR: In this article, a multisystem analysis of an SCN1A mouse model carrying the NaV1.1-R1648H mutation was presented, which causes febrile seizures and epilepsy in humans.
Journal ArticleDOI
Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19.
Daniel Kirschenbaum,Lukas L. Imbach,Elisabeth J. Rushing,Katrin Frauenknecht,R T Dominic Gascho,Benjamin V. Ineichen,Emanuela Keller,Sibylle Kohler,Mona Lichtblau,Regina Reimann,Katharina Schreib,Silvia Ulrich,Peter Steiger,Adriano Aguzzi,Karl Frontzek +14 more
TL;DR: Cerebral microhemorrhages in COVID‐19 patients could be a consequence of Sars‐ CoV‐2‐induced endotheliitis and more general vasculopathic changes and may correlate with an increased risk of vascular encephalopathy.
Journal ArticleDOI
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.
Emanuela Keller,Giovanna Brandi,Sebastian Winklhofer,Lukas L. Imbach,Daniel Kirschenbaum,Karl Frontzek,Peter Steiger,Sabeth Aurelia Dietler,Marcellina Isabelle Haeberlin,Jan Willms,Francesca Porta,Adrian Waeckerlin,Michael Huber,Irene A Abela,Andreas Lutterotti,Christoph Stippich,Christoph Globas,Zsuzsanna Varga,Ilijas Jelcic +18 more
TL;DR: Different mechanisms of cerebrovascular disorders might be involved in COVID-19, which may lead to long-term disabilities and mechanisms should be urgently investigated to develop neuroprotective strategies.
Journal ArticleDOI
Inflammatory olfactory neuropathy in two patients with COVID-19.
Daniel Kirschenbaum,Lukas L. Imbach,Silvia Ulrich,Elisabeth J. Rushing,Emanuela Keller,Regina Reimann,Katrin Frauenknecht,Mona Lichtblau,Martin Witt,Thomas Hummel,Peter Steiger,Adriano Aguzzi,Karl Frontzek +12 more
TL;DR: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage in CRASH2: a randomised, placebocontrolled trial.